Skip to main content
Top
Published in: Supportive Care in Cancer 10/2012

01-10-2012 | Original Article

Changing preferences for information and participation in the last phase of life: a longitudinal study among newly diagnosed advanced lung cancer patients

Authors: Koen Pardon, R. Deschepper, R. Vander Stichele, J. L. Bernheim, F. Mortier, N. Bossuyt, D. Schallier, P. Germonpré, D. Galdermans, W. Van Kerckhoven, L. Deliens, on behalf of the EOLIC-consortium

Published in: Supportive Care in Cancer | Issue 10/2012

Login to get access

Abstract

Purpose

The objective is to explore changes over time in the information and participation preferences of newly diagnosed stage IIIb/IV non-small-cell lung cancer patients.

Methods

Patients were recruited by physicians in 13 hospitals and interviewed every 2 months until the fourth and every 4 months until the sixth interview.

Results

Sixty-seven patients were interviewed three times. Over a period of 4 months from diagnosis, half of patients changed their information preferences for palliative care and end-of-life decisions with a possible or certain life-shortening effect (ELDs, e.g., non-treatment decisions) in both directions, from not wanting to wanting the information, but also—and as much—from wanting to no longer wanting it. The latter were more likely to be in a better physical condition. Preferences for participation in medical decision making also changed: 50% to 78%, depending on the type of decision (general, treatment, transfer or ELD), changed their preference towards wanting more or less participation. Pain seemed to be a trigger for patients wanting more involvement, which contrasts with studies suggesting that patients who are more ill tend to give up more control.

Conclusions

Doctors should regularly ask their advanced lung cancer patients how much information and participation they want because preferences do change in unexpected ways.
Literature
1.
go back to reference American College of Physicians Ethics Manual. Third edition (1992) Ann Intern Med 117: 947–960 American College of Physicians Ethics Manual. Third edition (1992) Ann Intern Med 117: 947–960
2.
go back to reference Emanuel EJ, Emanuel LL (1992) Four models of the physician–patient relationship. JAMA 267:2221–2226PubMedCrossRef Emanuel EJ, Emanuel LL (1992) Four models of the physician–patient relationship. JAMA 267:2221–2226PubMedCrossRef
3.
go back to reference Arora NK (2003) Interacting with cancer patients: the significance of physicians' communication behavior. Soc Sci Med 57:791–806PubMedCrossRef Arora NK (2003) Interacting with cancer patients: the significance of physicians' communication behavior. Soc Sci Med 57:791–806PubMedCrossRef
4.
go back to reference Dias L, Chabner BA, Lynch TJ Jr, Penson RT (2003) Breaking bad news: a patient's perspective. Oncologist 8:587–596PubMedCrossRef Dias L, Chabner BA, Lynch TJ Jr, Penson RT (2003) Breaking bad news: a patient's perspective. Oncologist 8:587–596PubMedCrossRef
5.
go back to reference de Haes H, Koedoot N (2003) Patient centered decision making in palliative cancer treatment: a world of paradoxes. Patient Educ Couns 50:43–49PubMedCrossRef de Haes H, Koedoot N (2003) Patient centered decision making in palliative cancer treatment: a world of paradoxes. Patient Educ Couns 50:43–49PubMedCrossRef
6.
go back to reference Deschepper R, Bernheim JL, Vander Stichele R, Van den Block L, Michiels E, Van Der Kelen G, Mortier F, Deliens L (2008) Truth-telling at the end of life: a pilot study on the perspective of patients and professional caregivers. Patient Educ Couns 71:52–56PubMedCrossRef Deschepper R, Bernheim JL, Vander Stichele R, Van den Block L, Michiels E, Van Der Kelen G, Mortier F, Deliens L (2008) Truth-telling at the end of life: a pilot study on the perspective of patients and professional caregivers. Patient Educ Couns 71:52–56PubMedCrossRef
7.
go back to reference de Haes H (2006) Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns 62:291–298PubMedCrossRef de Haes H (2006) Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns 62:291–298PubMedCrossRef
8.
go back to reference Bernheim J (2001) The doctor's dilemma between patient autonomy and physician beneficence at the end of life II. A patient–physician information and covenant (ICC) as a procedural–ethical solution. Ethiek en Maatschappij 4:114–121 (In Dutch) Bernheim J (2001) The doctor's dilemma between patient autonomy and physician beneficence at the end of life II. A patient–physician information and covenant (ICC) as a procedural–ethical solution. Ethiek en Maatschappij 4:114–121 (In Dutch)
9.
go back to reference Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84:48–51PubMedCrossRef Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84:48–51PubMedCrossRef
10.
go back to reference Gaston CM, Mitchell G (2005) Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 61:2252–2264PubMedCrossRef Gaston CM, Mitchell G (2005) Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 61:2252–2264PubMedCrossRef
11.
go back to reference Davidson JR, Brundage MD, Feldman-Stewart D (1999) Lung cancer treatment decisions: patients' desires for participation and information. Psychooncology 8:511–520PubMedCrossRef Davidson JR, Brundage MD, Feldman-Stewart D (1999) Lung cancer treatment decisions: patients' desires for participation and information. Psychooncology 8:511–520PubMedCrossRef
12.
go back to reference Gattellari M, Butow PN, Tattersall MH (2001) Sharing decisions in cancer care. Soc Sci Med 52:1865–1878PubMedCrossRef Gattellari M, Butow PN, Tattersall MH (2001) Sharing decisions in cancer care. Soc Sci Med 52:1865–1878PubMedCrossRef
13.
go back to reference Curtis JR, Engelberg R, Young JP, Vig LK, Reinke LF, Wenrich MD, McGrath B, McCown E, Back AL (2008) An approach to understanding the interaction of hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced cancer. J Palliat Med 11:610–620PubMedCrossRef Curtis JR, Engelberg R, Young JP, Vig LK, Reinke LF, Wenrich MD, McGrath B, McCown E, Back AL (2008) An approach to understanding the interaction of hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced cancer. J Palliat Med 11:610–620PubMedCrossRef
14.
go back to reference Butow PN, Maclean M, Dunn SM, Tattersall MH, Boyer MJ (1997) The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef Butow PN, Maclean M, Dunn SM, Tattersall MH, Boyer MJ (1997) The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef
15.
go back to reference Wet betreffende palliatieve zorg 14 juni 2002. Belgisch Staatsblad 26 oktober 2002. [Law concerning palliative care June 14, 2002. Belgian official collection of the Laws October 26, 2002] (in Dutch) Wet betreffende palliatieve zorg 14 juni 2002. Belgisch Staatsblad 26 oktober 2002. [Law concerning palliative care June 14, 2002. Belgian official collection of the Laws October 26, 2002] (in Dutch)
16.
go back to reference National cancer control programmes: policies and managerial guidelines (2002) Geneva: World Health Organisation National cancer control programmes: policies and managerial guidelines (2002) Geneva: World Health Organisation
17.
go back to reference Bilsen J, Cohen J, Chambaere K, Pousset G, Onwuteaka-Philipsen BD, Mortier F, Deliens L (2009) Medical end-of-life practices under the euthanasia law in Belgium. N Engl J Med 361:1119–1121PubMedCrossRef Bilsen J, Cohen J, Chambaere K, Pousset G, Onwuteaka-Philipsen BD, Mortier F, Deliens L (2009) Medical end-of-life practices under the euthanasia law in Belgium. N Engl J Med 361:1119–1121PubMedCrossRef
18.
go back to reference van der Heide A, Deliens L, Faisst K, Nilstun T, Norup M, Paci E, Van Der WG, van der Maas PJ (2003) End-of-life decision-making in six European countries: descriptive study. Lancet 362:345–350PubMedCrossRef van der Heide A, Deliens L, Faisst K, Nilstun T, Norup M, Paci E, Van Der WG, van der Maas PJ (2003) End-of-life decision-making in six European countries: descriptive study. Lancet 362:345–350PubMedCrossRef
19.
go back to reference Bonomi P, Kim K, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D (2000) Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18:623–631PubMed Bonomi P, Kim K, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D (2000) Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18:623–631PubMed
20.
go back to reference Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH (2004) Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial—INTACT 2. J Clin Oncol 22:785–794PubMedCrossRef Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH (2004) Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial—INTACT 2. J Clin Oncol 22:785–794PubMedCrossRef
21.
go back to reference Wen KY, Gustafson DH (2004) Needs assessment for cancer patients and their families. Health Qual Life Outcome 2:11CrossRef Wen KY, Gustafson DH (2004) Needs assessment for cancer patients and their families. Health Qual Life Outcome 2:11CrossRef
22.
go back to reference Kutner JS, Steiner JF, Corbett KK, Jahnigen DW, Barton PL (1999) Information needs in terminal illness. Soc Sci Med 48:1341–1352PubMedCrossRef Kutner JS, Steiner JF, Corbett KK, Jahnigen DW, Barton PL (1999) Information needs in terminal illness. Soc Sci Med 48:1341–1352PubMedCrossRef
23.
go back to reference Degner LF, Sloan JA, Venkatesh P (1997) The control preferences scale. Can J Nurs Res 29:21–43PubMed Degner LF, Sloan JA, Venkatesh P (1997) The control preferences scale. Can J Nurs Res 29:21–43PubMed
24.
go back to reference Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64PubMedCrossRef Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64PubMedCrossRef
25.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
26.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
27.
go back to reference Cleveland WS, Devlin SJ (1988) Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 83:596–610CrossRef Cleveland WS, Devlin SJ (1988) Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 83:596–610CrossRef
28.
go back to reference Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH (2007) A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag 34:81–93CrossRef Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH (2007) A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag 34:81–93CrossRef
29.
go back to reference Street RL, Gordon HS (2008) Companion participation in cancer consultations. Psychooncology 17:244–251PubMedCrossRef Street RL, Gordon HS (2008) Companion participation in cancer consultations. Psychooncology 17:244–251PubMedCrossRef
30.
go back to reference Degner LF, Sloan JA (1992) Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 45:941–950PubMedCrossRef Degner LF, Sloan JA (1992) Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 45:941–950PubMedCrossRef
Metadata
Title
Changing preferences for information and participation in the last phase of life: a longitudinal study among newly diagnosed advanced lung cancer patients
Authors
Koen Pardon
R. Deschepper
R. Vander Stichele
J. L. Bernheim
F. Mortier
N. Bossuyt
D. Schallier
P. Germonpré
D. Galdermans
W. Van Kerckhoven
L. Deliens
on behalf of the EOLIC-consortium
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1369-4

Other articles of this Issue 10/2012

Supportive Care in Cancer 10/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine